Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. Purified p30 has been tested for its potential to induce protective immunity in mice and for serodiagnosis of Toxoplasma infection.
FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)
(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.